Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A
Muhammad Osama Siddiqui1, Mohammad Ali Syed1, Ayaan Ahmed Qureshi1
1Liaquat National Hospital and Medical College, MBBS, Karachi, Pakistan.
Insights
Giant cell arteritis (GCA) patients face a high risk of cerebrovascular ischemic events (CIE) upon diagnosis. Early intervention with risk factor management and medications like aspirin can significantly reduce CIE incidence and severity.
Area of Science:
- Vascular Medicine
- Neurology
- Rheumatology
Background:
- Giant cell arteritis (GCA) is a vasculitis affecting large vessels, with cerebrovascular ischemic events (CIE) being a serious complication.
- CIE, including stroke, can occur in up to 4% of GCA patients, with a heightened risk in the initial weeks post-diagnosis.
Purpose of the Study:
- To identify key risk factors for GCA-related CIE.
- To outline pharmacological interventions for preventing and managing CIE in GCA patients.
- To aid physicians in better managing GCA patients and reducing CIE risk.
Main Methods:
- A narrative review of literature from 2000-2024 was conducted.
- Searches were performed across major medical databases including Pubmed, Google Scholar, and Scopus.
- The review focused on incidence, pathology, risk factors, and management of GCA-related CIE.
Main Results:
- Age, male gender, hypertension, and smoking are significant risk factors for CIE.
- Anemia, higher BMI, and elevated inflammatory markers (CRP, ESR) may offer protective effects.
- Ophthalmic artery ischemia is the strongest predictor of CIE; glucocorticoids, tocilizumab, aspirin, and antiplatelet agents show promise in management.
Conclusions:
- Early diagnosis and risk factor management are crucial for preventing debilitating GCA-related CIE.
- Ophthalmic artery ischemia strongly predicts CIE, and early aspirin/antiplatelet therapy may be beneficial.
- Further research into risk factor analysis is needed to refine CIE risk stratification and mitigation strategies in GCA.
Introduction:
Giant cell arteritis (GCA) is a common vasculitis predominantly affecting larger vessels, especially in individuals aged 70-79. Cerebrovascular ischemic events (CIE), such as stroke and transient ischemic attacks, are serious but rare complications of GCA, with a pooled prevalence of 4%. Some studies found that within 2 weeks of GCA diagnosis, 74% and 34% of patients experience transient or severe ischemic events, respectively.
Aims:
Our study aims to help physicians better manage GCA patients to reduce GCA-related CIE by indicating important risk factors and pharmacological intervention to prevent GCA-related CIE, particularly in the first few days of diagnosis when the risk of CIE is highest.
Methods:
A comprehensive literature search was conducted using Pubmed, Google Scholar, Scopus, and other relevant medical databases. As this study was a narrative review, the literature search was done in a nonsystematic manner. Studies published from 2000 to 2024 were reviewed in a nonsystematic manner for information on incidence, pathology, risk factors, pharmacological intervention, and management of GCA-related CIE.
Results:
Findings indicate that age, male gender, hypertension, and smoking significantly increase the risk of GCA-related CIE, while factors such as anemia, higher body mass index (BMI), and elevated inflammatory markers (C-reactive protein [CRP] and erythrocyte sedimentation rate [ESR]) appear to have protective effects. Symptoms of ischemia in the ophthalmic artery were identified as the strongest predictors of CIE. Pharmacological treatments, including glucocorticoids and tocilizumab, are instrumental in managing and potentially preventing CIE in GCA patients, with adjunctive therapies such as aspirin and antiplatelet agents also showing promise.
Conclusion:
GCA-related CIE such as stroke can be very debilitating and deadly conditions, particularly when GCA is initially diagnosed. However, with early diagnosis and proper management of risk factors, GCA-related CIE can be prevented and its severity can be reduced. Ischemia in the ophthalmic artery is found to strongly predict GCA-related CIE while aspirin and antiplatelet agent during the first 3 months may prevent GCA-related CIE. Risk factors such as BMI and smoking may help in stratifying the risk of GCA-related CIE. This review underscores the importance of further studies with detailed, well-designed approaches to risk factor analysis to strengthen these associations. Identifying these risk factors is crucial for reducing morbidity and mortality, equipping physicians to better assess and mitigate the risk of CIE in GCA patients.
More Related Videos
Related Concept Videos
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System